UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 4 (121) » PSYCHOTHERAPY TACTICS FOR MENTAL DISORDERS AFTER SUFFERING FROM THE COVID-19 CORONAVIRUS DISEASE

PSYCHOTHERAPY TACTICS FOR MENTAL DISORDERS AFTER SUFFERING FROM THE COVID-19 CORONAVIRUS DISEASE

Authors

Type of Article

  • Scientific Article

In the Section

  • diagnosis and treatment of mental and behavioral disorders.

Key words

Index UDK:
  • 616.89-052:616.9-071-08

Abstract

  • The COVID-19 pandemic causes numerous physical and mental consequences that significantlyworsen the health and social functioning of the population. It has been established that a widerange of mental disorders (anxiety and depressive disorders, post-traumatic stress disorders,eating disorders) and psychological disorders (stress reactions, sadness, feelings of isolation)are developing under the influence of the COVID-19 pandemic. The COVID-19 pandemic causesnumerous physical and mental consequences that significantly worsen the health and socialfunctioning of the population.The purpose of the study: development of complex psychotherapy for mental disorders dueto the transferred coronavirus disease COVID-19. The study included 63 cases with mental disorders after a cardiac infection of COVID-19.The diagnosis was made according to the ICD-10 criteria: mood disorders (affective disorders)(F32.0 — F32.2) — 34 patients, neurotic, stress-related and somatoform disorders (F40 — F45) —32 patients, other mental disorders caused by the injury or brain dysfunction or as a resultof somatic disease (F06.3 — F06.6) — 31 patients.The data obtained as a result of the study indicate that as a result of the coronavirus diseaseCOVID-19, various mental disorders occur within the limits of neurotic, stress-related and somatoform disorders, affective disorders and mental disorders of organic origin. Mental disorders dueto the coronavirus disease COVID-19 are characterized by a complex of changes in the mentalstate and psychological instructions, which significantly worsens the condition of patients. Suchchanges include not only clinical and psychopathological symptoms, but also pathologicalchanges in coping strategies, the level of adaptability, frustration tolerance and quality of life.Also, a complex of psychotraumatic factors, which complicates the course of mental disorders,makes a significant contribution to the course of the disorder. All this requires a complex specificapproach to the therapy of mental disorders due to the coronavirus disease COVID-19, whichshould include both pharmacotherapy and psychotherapy. Pharmacotherapy is prescribed takinginto account the dominant clinical symptoms. Thus, with the severity of depressive symptoms,antidepressants from the group of selective serotonin reuptake inhibitors or selective serotoninand norepinephrine reuptake inhibitors are prescribed; with the severity of an alarming symptom complex — anxiolytics. In addition, it is advisable to use general strengthening drugs and,if necessary, vascular drugs. The data obtained as a result of the study indicate that as a resultof the coronavirus disease COVID-19, various mental disorders occur within the limits of neurotic,stress-related and somatoform disorders, affective disorders and mental disorders of organicorigin. Mental disorders due to the coronavirus disease COVID-19 are characterized by a complex of changes in the mental state and psychological instructions, which significantly worsensthe condition of patients. Such changes include not only clinical and psychopathological symptoms, but also pathological changes in coping strategies, the level of adaptability, frustrationtolerance and quality of life. Also, a complex of psychotraumatic factors, which complicatesthe course of mental disorders, makes a significant contribution to the course of the disorder.All this requires a complex specific approach to the therapy of mental disorders due to thecoronavirus disease COVID-19, which should include both pharmacotherapy and psychotherapy.Pharmacotherapy is prescribed taking into account the dominant clinical symptoms. Thus, withthe severity of depressive symptoms, antidepressants from the group of selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors are prescribed; withthe severity of an alarming symptom complex — anxiolytics. In addition, it is advisable to usegeneral strengthening drugs and, if necessary, vascular drugs.Psychotherapy should be staged and sequential in nature: 1st stage — informative anddiagnostic, 2nd stage — therapeutic and stabilizing, 3rd stage — rehabilitative, 4th stage — preventive. Each stage includes various techniques of CBT, NET, art therapy, family psychotherapy.The implementation of this approach proves its effectiveness. According to the developedsystem, 63 patients with mental disorders after the coronavirus disease COVID-19 were treated(F40 — F45 — 22 patients, F32.0 — F32.2 — 21 patients, F06.3 — F06.6 — 20 patients). Afterthe therapy, 76.19 % showed significant improvement, 14.28 % showed improvement, and 9.53 %showed slight improvement.

Pages

  • 14-22

Year / Issue

Download PDF

Bibliography

1. World Health Organization. COVID-19 Weekly Epidemiological Update. (2023). URI: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-COVID-19—17-august-2023 (accessed March 19, 2023).
2. Eissazade N, Shalbafan M, Saeed F, Hemmati D, Askari S,Sayed Mirramazani M, et al. The impact of the COVID-19 pandemic on Iranian psychiatric trainees’ and early career psychiatrists’ well-being, work conditions, and education. AcadPsychiatry. (2022) 46:710–7. doi:10.1007/s40596-022-01674-5.
3. Xu X, Zhang J, Fang R, Liu H, Zhou W, She Y, et al. Evaluation of the mental health status of community frontline medical workers after the normalized management of COVID-19in Sichuan, China. Front Psychiatry.  (2023) 14:1198822. doi: 10.3389/fpsyt.2023.1198822.
4. Adiukwu F, Kamalzadeh L, Pinto da Costa M, Ransing R,de Filippis R, Pereira-Sanchez V, et al. The grief experience duringthe COVID-19 pandemic across different cultures. Ann Gen Psychiatry. (2022) 21:18. doi: 10.1186/s12991-022-00397-z.
5. Ullah I, Khan KS, Ali I, Ullah AR, Mukhtar S, de Filippis R, et al.Depression and anxiety among Pakistani healthcare workers amid COVID-19 pandemic: a qualitative study. Ann Med Surg. (2022)78:103863. doi: 10.1016/j.amsu.2022.103863.
6. Ashiq MAR, Gupta PS, Jubayer Biswas MAA, Ahmed N,Sultana MstS, Ghosh B, et al. Depression, anxiety, stress, andfear of COVID-19 among Bangladeshi medical students duringthe first wave of the pandemic: a mixed-methods study. FrontPsychiatry. (2023) 14:1142724. doi: 10.3389/fpsyt.2023.1142724.
7. Anteneh RM, Dessie AM, Azanaw MM, Anley DT, MeleseBD, Feleke SF, et  al. The  psychological impact of  COVID-19pandemic and associated factors among college and universitystudents in Ethiopia: a systematic review and meta-analysis,2022. Front Public Health. (2023) 11:1136031. doi: 10.3389/fpubh.2023.1136031.
8. Zenba Y, Kobayashi A, Imai T. Psychological distress is affected by fear of COVID-19 via lifestyle disruption and leisurerestriction among older adults in  Japan: a  cross-sectionalstudy. Front Public Health. (2023) 11:1264088. doi: 10.3389/fpubh.2023.1264088.
9. Tahmasebi S, Khosh E, Esmaeilzadeh A. The outlook fordiagnostic purposes of the 2019-novel coronavirus disease.J Cell Physiol. (2020) 235:9211–29. doi: 10.1002/jcp.29804.
10. World Health Organization. #HealthyAtHome – MentalHealth. URI: https://www.who.int/campaigns/connecting-theworld-to-combat-coronavirus/healthyathome/healthyathome—mental-health (accessed March 19, 2023).
11. Jones EAK, Mitra AK, Bhuiyan AR. Impact of COVID-19 on mental health in adolescents: a systematic review.Int J Environ Res Public Health. (2021) 18:2470. doi: 10.3390/ijerph18052470.
12. Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problemsin COVID-19: a review. F1000Res. (2020) 9:636. doi: 10.12688/f1000research.24457.1.
13. Guessoum SB, Lachal J, Radjack R, Carretier E, Minassian S, Benoit L, Moro MR. Adolescent psychiatric disordersduring the COVID-19 pandemic and lockdown. Psychiatry Res.(2020) 291:113264. doi: 10.1016/ j.psychres. 2020.113264.
14. Singh S, Roy D, Sinha K, Parveen S, Sharma G, Joshi G. Impact of COVID-19 and lockdown on mental health of children andadolescents: a narrative review with recommendations. PsychiatryRes. (2020) 293:113429. doi: 10.1016/j.psychres.2020.113429.
15. Nalbandian A., Sehgal K., Gupta et  al. Post-acuteCOVID-19 syndrome. Nat Med. 2021. Vol. 27. P. 601–615. doi:10.1038/s41591-021-01283-z.
16. Witthöft, M., & Hiller, W. (2010). Psychological approachesto origins and treatments of somatoform disorders. Annual Review of Clinical Psychology, 6(1), 257–283. doi: 10.1146/annurev.clinpsy.121208.131505.
17. Ingman, T., Smakowski, A., Goldsmith, K., & Chalder, T.(2022). A systematic literature review of randomized controlledtrials evaluating prognosis following treatment for adults withchronic fatigue syndrome. Psychological Medicine, 52(14), 2917–2929. doi: 10.1017/S0033291722002471.
18. Kleinstäuber, M., Allwang, C., Bailer, J., Berking, M., Brünahl, C., Erkic, M., … Rief, W. (2019). Cognitive behaviour therapycomplemented with emotion regulation training for patientswith persistent physical symptoms: A  randomised clinicaltrial. Psychotherapy and Psychosomatics, 88(5), 287–299. doi:10.1159/000501621.
19. Price, J. R., Mitchell, E., Tidy, E., & Hunot, V. (2008). Cognitive behaviour therapy for chronic fatigue syndrome in adults.Cochrane Database of Systematic Reviews,  3:CD001027. doi:10.1002/14651858.CD001027.pub2.
20. Van Dessel, N., den Boeft, M., van der Wouden, J. C., Kleinstäuber, M., Leone, S. S., Terluin, B., … van Marwijk, H. W. (2014).Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS)in adults. Cochrane Database of Systematic Reviews, 11, CD011142.doi: 10.1002/14651858.CD011142.pub2.
21. Maruta N. O., Fedchenko V. Iu., Yavdak I. O., Panko T. V., Semikina O. Ie. Copyrightof the work: Questionnaire for patients with mental disorders whohave experienced the coronavirus disease COVID-19 and  wereexposed to the stressors of the SARS-COV-2 pandemic; application from March 13, 2023 p202301564; certificate dated April11, 2023 No. 118009. (In Ukrainian).
22. Velichkovskiy B. B. Multidimensional assessment of individual resistance to stress. Bulletin of MoscowState Regional University. 2007. No. 3. P. 105-112. (In Russian).
23. Multilevel personality questionnaire "Adaptability"(MLO-AM) by A. G. Maklakov and S. V. Chermyanin. Practical psychodiagnostics. Methods and tests]: a tutorial / ed. and compiledby Raigorodsky D. Ya. Samara, 2006. Pp. 549-672. (In Russian).
24. Wasserman L. I., Iovlev B. V., Berebin M. A. [Methodologyfor psychological diagnostics of the level of social frustration andits practical application: methodological recommendations].Moscow: NIPNI im. Bekhterev, 2004. 28 p. (In Russian).
25. Methodology for assessing the quality of life of patients and disabled people: methodological recommendations. Minsk, 2000.25 p. (In Russian).

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»